Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance

Viswanath Das, Arun Kanakkanthara, Ariane Chan, John H. Miller

Research output: Contribution to journalShort survey

6 Citations (Scopus)

Abstract

Polyglutamylation of tubulin and other non-tubulin substrates is a reversible posttranslational modification brought about by tubulin tyrosine-like ligases. Altered polyglutamylation is linked to tumorigenesis and resistance to chemotherapeutic drugs that target the microtubule, and therefore is a potential pharmacological target in cancer therapy. Despite the large amount of research focused on the development of anticancer agents, only a small number of well-characterized inhibitors of polyglutamylases have been identified, including the phosphinic acid-based inhibitors of Ttll7. In this minireview, we summarize the role of polyglutamylation in cancer, and draw attention to the largely unexplored area of polyglutamylase inhibition in the treatment of cancer.

Original languageEnglish (US)
Pages (from-to)1-4
Number of pages4
JournalCancer Letters
Volume350
Issue number1-2
DOIs
StatePublished - Aug 1 2014

Fingerprint

Carcinogenesis
Enzymes
Phosphinic Acids
Neoplasms
Post Translational Protein Processing
Tubulin
Microtubules
Antineoplastic Agents
Pharmacology
Research
Pharmaceutical Preparations
tyrosyltubulin ligase
Therapeutics

Keywords

  • Cancer resistance
  • Microtubule
  • Polyglutamylation
  • Polyglutamylation inhibitors
  • Tumorigenesis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance. / Das, Viswanath; Kanakkanthara, Arun; Chan, Ariane; Miller, John H.

In: Cancer Letters, Vol. 350, No. 1-2, 01.08.2014, p. 1-4.

Research output: Contribution to journalShort survey

Das, Viswanath ; Kanakkanthara, Arun ; Chan, Ariane ; Miller, John H. / Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance. In: Cancer Letters. 2014 ; Vol. 350, No. 1-2. pp. 1-4.
@article{e1fcb8388b7043fbb392084a2eb67f2a,
title = "Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance",
abstract = "Polyglutamylation of tubulin and other non-tubulin substrates is a reversible posttranslational modification brought about by tubulin tyrosine-like ligases. Altered polyglutamylation is linked to tumorigenesis and resistance to chemotherapeutic drugs that target the microtubule, and therefore is a potential pharmacological target in cancer therapy. Despite the large amount of research focused on the development of anticancer agents, only a small number of well-characterized inhibitors of polyglutamylases have been identified, including the phosphinic acid-based inhibitors of Ttll7. In this minireview, we summarize the role of polyglutamylation in cancer, and draw attention to the largely unexplored area of polyglutamylase inhibition in the treatment of cancer.",
keywords = "Cancer resistance, Microtubule, Polyglutamylation, Polyglutamylation inhibitors, Tumorigenesis",
author = "Viswanath Das and Arun Kanakkanthara and Ariane Chan and Miller, {John H.}",
year = "2014",
month = "8",
day = "1",
doi = "10.1016/j.canlet.2014.04.022",
language = "English (US)",
volume = "350",
pages = "1--4",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance

AU - Das, Viswanath

AU - Kanakkanthara, Arun

AU - Chan, Ariane

AU - Miller, John H.

PY - 2014/8/1

Y1 - 2014/8/1

N2 - Polyglutamylation of tubulin and other non-tubulin substrates is a reversible posttranslational modification brought about by tubulin tyrosine-like ligases. Altered polyglutamylation is linked to tumorigenesis and resistance to chemotherapeutic drugs that target the microtubule, and therefore is a potential pharmacological target in cancer therapy. Despite the large amount of research focused on the development of anticancer agents, only a small number of well-characterized inhibitors of polyglutamylases have been identified, including the phosphinic acid-based inhibitors of Ttll7. In this minireview, we summarize the role of polyglutamylation in cancer, and draw attention to the largely unexplored area of polyglutamylase inhibition in the treatment of cancer.

AB - Polyglutamylation of tubulin and other non-tubulin substrates is a reversible posttranslational modification brought about by tubulin tyrosine-like ligases. Altered polyglutamylation is linked to tumorigenesis and resistance to chemotherapeutic drugs that target the microtubule, and therefore is a potential pharmacological target in cancer therapy. Despite the large amount of research focused on the development of anticancer agents, only a small number of well-characterized inhibitors of polyglutamylases have been identified, including the phosphinic acid-based inhibitors of Ttll7. In this minireview, we summarize the role of polyglutamylation in cancer, and draw attention to the largely unexplored area of polyglutamylase inhibition in the treatment of cancer.

KW - Cancer resistance

KW - Microtubule

KW - Polyglutamylation

KW - Polyglutamylation inhibitors

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84901493793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901493793&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2014.04.022

DO - 10.1016/j.canlet.2014.04.022

M3 - Short survey

VL - 350

SP - 1

EP - 4

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1-2

ER -